Equity Profile

ZLAB

Zai Lab Limited

Health CareBiotechnology$2.9B

Nov29Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close9:00 AM EST

Company Snapshot

Zai Lab Limited is a biotechnology company focused on developing innovative medicines to treat cancer and other serious diseases. Operating in the healthcare sector, Zai Lab is significant for its potential to address unmet medical needs in a rapidly evolving industry.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and commercialize its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZLAB Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+0.83%

Avg Stock Reaction

-3.30%

Last Quarter Recap

In Q1-2026, Zai Lab reported an EPS of -$0.46, which was better than the expected -$0.58, leading to a positive surprise of 20.69%. However, the stock dropped 5.93% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, there is uncertainty surrounding Zai Lab's upcoming earnings, especially given the lack of analyst estimates and management guidance. Investors will be looking for signs of improvement in profitability and revenue growth.

Bull Case

If Zai Lab can demonstrate strong revenue growth and improved EPS, it could signal that the company's products are gaining traction in the market, leading to a positive reaction from investors.

Bear Case

Conversely, if the company fails to meet expectations for revenue or shows continued losses, it could raise concerns about its long-term viability and lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and how does it compare to previous quarters?

EPS is a critical measure of profitability, and any improvement could boost investor confidence.

What are the revenue figures for the quarter, and how do they align with market expectations?

Revenue growth is essential for Zai Lab's future prospects, and any shortfall could negatively impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Zai Lab's potential for revenue growth due to its innovative pipeline, which could lead to surprises in upcoming quarters.

Supporting Evidence

The options market is pricing a significant move, indicating that traders expect volatility, which may not align with current consensus.

Zai Lab's recent EPS surprise of +20.69% suggests that the company has the potential to outperform expectations.

Key Risk

If Zai Lab reports revenue growth above 15%, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing Zai Lab's ability to turn around its financial performance, making these metrics critical for investor sentiment.

Bull Confirmed If

A revenue growth rate exceeding 15% compared to the previous quarter would confirm the bull case.

Bear Confirmed If

If EPS falls below -$0.50, it would raise serious concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±32.08%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±32.1% while ZLAB has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

60.2%

Calls (400)P/C Ratio: 52.33Puts (5K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zai Lab beats expectations, history suggests a potential stock increase of around 5.5%, confirming a positive outlook.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, as investors await further clarity on future guidance.

Miss

If the company misses expectations, history suggests a decline of about 1.1%, which could heighten concerns about its growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements and their expected market impact.
2Details on partnerships or collaborations that could enhance revenue potential.
3Management's outlook on market conditions and competitive landscape.
4Insights into cost management strategies and their effect on EPS.
5Any commentary on regulatory developments that could influence product approvals.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

The Buckle, Inc.

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market presence and commercialize its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

ZLAB Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+0.83%

Avg Stock Reaction

-3.30%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Zai Lab can demonstrate strong revenue growth and improved EPS, it could signal that the company's products are gaining traction in the market, leading to a positive reaction from investors.

Bear Case

Conversely, if the company fails to meet expectations for revenue or shows continued losses, it could raise concerns about its long-term viability and lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and how does it compare to previous quarters?

EPS is a critical measure of profitability, and any improvement could boost investor confidence.

What are the revenue figures for the quarter, and how do they align with market expectations?

Revenue growth is essential for Zai Lab's future prospects, and any shortfall could negatively impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Zai Lab's potential for revenue growth due to its innovative pipeline, which could lead to surprises in upcoming quarters.

Supporting Evidence

The options market is pricing a significant move, indicating that traders expect volatility, which may not align with current consensus.

Zai Lab's recent EPS surprise of +20.69% suggests that the company has the potential to outperform expectations.

Key Risk

If Zai Lab reports revenue growth above 15%, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing Zai Lab's ability to turn around its financial performance, making these metrics critical for investor sentiment.

Bull Confirmed If

A revenue growth rate exceeding 15% compared to the previous quarter would confirm the bull case.

Bear Confirmed If

If EPS falls below -$0.50, it would raise serious concerns about the company's financial health.

Pre-Earnings Positioning

Options Market

Implied Move

±32.08%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±32.1% while ZLAB has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

60.2%

Calls (400)P/C Ratio: 52.33Puts (5K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Zai Lab beats expectations, history suggests a potential stock increase of around 5.5%, confirming a positive outlook.

In-Line / Cautious

A cautious in-line report may lead to muted reactions, as investors await further clarity on future guidance.

Miss

If the company misses expectations, history suggests a decline of about 1.1%, which could heighten concerns about its growth trajectory.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product pipeline advancements and their expected market impact.
2Details on partnerships or collaborations that could enhance revenue potential.
3Management's outlook on market conditions and competitive landscape.
4Insights into cost management strategies and their effect on EPS.
5Any commentary on regulatory developments that could influence product approvals.